Sign In
Buy EFX
$152.53
-0.96 (-0.625%)
At Close: Jun 23, 2026
Equifax (EFX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
07:01pm, Wednesday, 17'th Jul 2024
While the top- and bottom-line numbers for Equifax (EFX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to
Equifax (EFX) Surpasses Q2 Earnings and Revenue Estimates
06:25pm, Wednesday, 17'th Jul 2024
Equifax (EFX) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.72 per share. This compares to earnings of $1.71 per share a year ago.
Equifax Delivers Strong Second Quarter 2024 Revenue Growth of 9% Led by Workforce Solutions Non-Mortgage Verification Services
04:09pm, Wednesday, 17'th Jul 2024
ATLANTA , July 17, 2024 /PRNewswire/ -- Equifax® (NYSE: EFX) today announced financial results for the quarter ended June 30, 2024. Second quarter 2024 revenue of $1.430 billion grew a strong 9%, w
Equifax (EFX) to Report Q2 Earnings: What's in the Offing?
10:56am, Friday, 12'th Jul 2024
Equifax's (EFX) second-quarter 2024 revenues are likely to have benefited from the rise in mortgage revenues, and higher revenues from Europe and Latin America.
Unveiling Equifax (EFX) Q2 Outlook: Wall Street Estimates for Key Metrics
10:20am, Friday, 12'th Jul 2024
Get a deeper insight into the potential performance of Equifax (EFX) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some o
Will Equifax (EFX) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Thursday, 11'th Jul 2024
Equifax (EFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FI vs. EFX: Which Stock Is the Better Value Option?
12:40pm, Thursday, 11'th Jul 2024
Investors interested in stocks from the Financial Transaction Services sector have probably already heard of Fiserv (FI) and Equifax (EFX). But which of these two stocks is more attractive to value in
Equifax (EFX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Wednesday, 10'th Jul 2024
Equifax (EFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Equifax Earnings Preview: Growth Numbers Do Not Support Its Price
04:01pm, Tuesday, 09'th Jul 2024
Equifax is set to report earnings numbers on the 17th of July. There are concerns about a potential revenue miss due to the tough mortgage environment and high-interest rates. The company's valuation
Equifax Announces Earnings Release Date and Conference Call for Second Quarter 2024 Results
01:20pm, Wednesday, 03'rd Jul 2024
ATLANTA , July 3, 2024 /PRNewswire/ -- Equifax ® (NYSE: EFX) will announce its financial results for the first quarter ended June 30, 2024, in a release to be issued on July 17, after the market clos
FI or EFX: Which Is the Better Value Stock Right Now?
12:40pm, Tuesday, 25'th Jun 2024
Investors interested in stocks from the Financial Transaction Services sector have probably already heard of Fiserv (FI) and Equifax (EFX). But which of these two stocks offers value investors a bette
Equifax Introduces Secondary Education Diploma Verification Solution for Employers
07:45am, Thursday, 20'th Jun 2024
New Talent Report™ Solution Helps Speed Up High School Diploma Verification for Employers and Screeners ATLANTA , June 20, 2024 /PRNewswire/ -- Equifax ® (NYSE: EFX) has introduced an education
Canadian Businesses Lean on New Installment Loans For Debt Repayment as Delinquencies Rise
04:49am, Tuesday, 18'th Jun 2024
- Interest Rate Cut May Bring Some Relief as Business Owners Grapple with Loan Repayments -
Keeping up with the Economy: Canadians Continue to Adapt their Credit and Financial Decisions
05:00am, Tuesday, 11'th Jun 2024
– Equifax Canada reports Quebec, Ontario and British Columbia Face the Highest Non-Mortgage Delinquency Rate Changes –
Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024
08:15am, Saturday, 08'th Jun 2024
SOUTH SAN FRANCISCO, Calif., June 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with
